XML 46 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense

The following table reflects the components of stock-based compensation expense recognized in our Consolidated Statements of Operations (in millions):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Research and development

 

$

33

 

 

$

29

 

 

$

11

 

General and administrative

 

 

32

 

 

 

26

 

 

 

11

 

Total stock-based compensation

 

$

65

 

 

$

55

 

 

$

22

 

Summary of Restricted Stock Units Activity

We grant restricted stock units (RSUs) to our employees and directors under the 2018 Plan. The RSUs vest annually or quarterly over four years for employees and annually for directors. The following table summarizes information regarding our RSUs for the year ended December 31, 2022:

 

 

Total Restricted Stock Units
(in millions)

 

 

Weighted
Average
Grant Date Fair Value

 

Nonvested at December 31, 2021

 

 

1.1

 

 

$

32.23

 

RSUs granted

 

 

0.9

 

 

 

30.22

 

RSUs vested

 

 

(0.5

)

 

 

32.27

 

RSUs forfeited or canceled

 

 

(0.2

)

 

 

30.65

 

Nonvested at December 31, 2022

 

 

1.3

 

 

$

31.09

 

Summary of Information Regarding Stock Options The following table summarizes information regarding our stock options for the year ended December 31, 2022:

 

 

Shares
Subject to
Outstanding
Options
(in millions)

 

 

Weighted
Average
Exercise
Price Per
Share

 

 

Weighted
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic
Value
(in millions)

 

Outstanding at December 31, 2021

 

 

12.0

 

 

$

19.46

 

 

 

 

 

 

 

Options granted

 

 

2.3

 

 

$

30.37

 

 

 

 

 

 

 

Options exercised

 

 

(1.4

)

 

$

13.17

 

 

 

 

 

 

 

Options forfeited or canceled

 

 

(0.9

)

 

$

25.93

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

12.0

 

 

$

21.77

 

 

 

7.60

 

 

$

50

 

Options vested and expected to vest as of December 31, 2022

 

 

12.0

 

 

$

21.77

 

 

 

7.60

 

 

$

50

 

Options exercisable as of December 31, 2022

 

 

6.7

 

 

$

18.01

 

 

 

7.01

 

 

$

42

 

Schedule of Assumptions Used to Calculate Fair Value and the Weighted-Average Grant Date Fair Value of Stock Options Granted The following table summarizes the key assumptions used to calculate the fair value and the resulting weighted-average grant date fair value of stock options granted:

 

 

 

Year Ended December 31,

 

Stock Options

 

2022

 

 

2021

 

 

2020

 

Weighted average closing price of our common stock on grant date

 

$

30.37

 

 

$

33.03

 

 

$

17.36

 

Risk-free interest rate

 

2.4% - 4.0%

 

 

1.0% - 1.4%

 

 

0.4% - 0.5%

 

Expected term (in years)

 

6.02

 

 

6.02

 

 

6.02

 

Volatility

 

76.5% - 79.3%

 

 

75.3% - 77.6%

 

 

76.5% - 78.5%

 

Dividend yield

 

0%

 

 

0%

 

 

0%

 

Weighted average fair value of stock options granted

 

$

20.75

 

 

$

22.05

 

 

$

11.57

 

 

 

 

Year Ended December 31,

ESPP

 

2022

 

2021

 

2020

Risk-free interest rate

 

1.6% - 4.7%

 

0.0% - 0.6%

 

0.1% - 0.2%

Expected term (in years)

 

0.5 - 2.0

 

0.5-2.0

 

0.5-2.0

Volatility

 

68.9% - 82.5%

 

61.2% - 95.7%

 

66.6% - 136.0%

Dividend yield

 

0%

 

0%

 

0%